Library

210 Results

Introduction to eLAS®

Introduction to eLAS®

Content provided by Clinical Ink | 08-Mar-2021 | Product Brochure

Clinical Ink has developed a unique offering — the electronic Lupus Assessment Suite (eLAS®) to address fundamental challenges impacting systemic lupus...

A Winning End-to-End Solution for Oncology Studies

A Winning End-to-End Solution for Oncology Studies

Content provided by Clinical Ink | 22-Feb-2021 | White Paper

Oncology clinical trials present a unique set of challenges for patients, study sites, and study sponsors. Using electronic patient reported outcomes (ePRO)...

Q&A: Effective Drug Product Process Development

Q&A: Effective Drug Product Process Development

Content provided by Catalent | 14-Jan-2021 | Insight Guide

In this Q&A, a Catalent Biologics expert shares his expertise with drug product process development challenges, risks and how to mitigate them, the...

Has EDC Kept Up With Changes In Clinical Trials?

Has EDC Kept Up With Changes In Clinical Trials?

Content provided by Oracle Health Sciences | 14-Dec-2020 | White Paper

In just a few decades, clinical trials have changed dramatically. Twenty years ago, most of the data used in clinical research was entered on paper, but...

Why Blister Packaging: Things to Consider

Why Blister Packaging: Things to Consider

Content provided by Catalent | 03-Dec-2020 | Insight Guide

The decision to use blister packaging for either clinical trials or commercial drug manufacturing comes with a host of factors to consider. Pharmaceutical...

Keys To A Successful Rapid Commercial Launch

Keys To A Successful Rapid Commercial Launch

Content provided by Catalent | 21-Oct-2020 | Insight Guide

Pharma and biotech companies are dedicating resources to new treatments with the hope of helping patients. The quicker they can get products to patients,...

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Content provided by Catalent | 03-Sep-2020 | Infographic

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

Content provided by PCM TRIALS | 01-Sep-2020 | White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

The Effect of Tamping Force on Bi-Layer Tablets

The Effect of Tamping Force on Bi-Layer Tablets

Content provided by JRS PHARMA | 15-Aug-2020 | White Paper

Formulation of bi-layer or multi-layer tablets enables the combination of two or more drugs that may be incompatible or maybe intended for delivery at...

Shifting the Biomanufacturing Paradigm

Shifting the Biomanufacturing Paradigm

Content provided by BioContinuum™ Platform - MilliporeSigma | 01-Jul-2020 | White Paper

Adoption of next generation processing and technologies can enable improvements in productivity by streamlining workflows, reducing the manufacturing plant...

Flow Cytometry Services

Flow Cytometry Services

Content provided by Q² Solutions | 01-Jun-2020 | Infographic

We are an established leader in flow cytometry services for clinical trials. Our technologies and solutions meet the growing global demand for enhanced...

Local lab Data Management

Local lab Data Management

Content provided by Q² Solutions | 01-May-2020 | Infographic

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...

Validating The Simoa Technology

Validating The Simoa Technology

Content provided by Frontage Laboratories | 01-Oct-2019 | White Paper

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Content provided by Zymewire | 15-Aug-2019 | White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Stability Testing As a Quality Control Measure

Stability Testing As a Quality Control Measure

Content provided by Frontage Laboratories | 19-Jun-2019 | White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Import Risks & Clinical Supply Depots

Import Risks & Clinical Supply Depots

Content provided by Catalent | 07-Nov-2018 | Case Study

A sponsor running a clinical trial in Israel arranged to ship their clinical trial product from Europe to a depot in Israel. With the protocol based in...

lyo_development

Lyophilization Scale-Up and Tech Transfer

Content provided by Baxter BioPharma Solutions | 12-Mar-2018 | White Paper

There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation...

Leveraging Best Practices in Primary Packaging

Leveraging Best Practices in Primary Packaging

Content provided by Catalent | 05-Mar-2018 | White Paper

When planning a clinical trial, overlooking the importance of primary packaging can be a mistake. From stability concerns to labeling to patient compliance...

SQ-USP-Brochure-Thumb-AP-CC

NEW…sugarcane derived USP Squalane from Aprinnova

Content provided by APRINNOVA – A joint venture of AMYRIS and NIKKOL Group | 26-Feb-2018 | Product Brochure

To date, topical formulation chemists have been restricted to using Squalane derived from the harvesting of shark livers. Neossance Squalane USP, derived...

lyo_vials

Process Development for Lyophilized Products

Content provided by Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...

How to get reproducible DNA amplification

How to get reproducible DNA amplification

Content provided by Eppendorf Bioprocess Solutions | 27-Jun-2017 | Infographic

DNA concentration, mastermix preparation, temperature management: Doing PCR like a pro can be more complex than it seems.The Eppendorf infographic helps...

Elemental Impurities Regulations View from a CRO

Elemental Impurities Regulations View from a CRO

Content provided by RSSL | 02-Nov-2016 | White Paper

Regulatory control of elemental impurities in pharmaceutical products has long been discussed, with both the European Pharmacopeia (EP) and the United...

Prefilled Syringe Contract Manufacturing

Prefilled Syringe Contract Manufacturing

Content provided by Baxter BioPharma Solutions | 15-Aug-2016 | Product Brochure

As a global contract manufacturing leader in prefilled syringe fill-finish, BioPharma Solutions offers clinical through high-volume commercial sterile...

PC1-16-0007B_610x343

Pharma-Introducing Pfizer CentreOne™

Content provided by Pfizer CentreOne | 27-Jul-2016 | Product Brochure

Pfizer CentreOne™ is a global contract manufacturer that focuses on API synthesis and sterile injectables fill-finish. For 40+ years, we've manufactured...

PEPTIDES & OLIGONUCLEOTIDES

PEPTIDES & OLIGONUCLEOTIDES

Content provided by SANOFI - CEPiA | 09-Nov-2015 | White Paper

From a unique state-of-the-art platform for development and scale-up of Peptides and Oligonucleotides in Frankfurt (Germany), CEPiA offers customized services...

Follow us

Products

View more

Webinars

Featured Suppliers

All